These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 15381544

  • 1. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.
    Tancrède-Bohin E, Ionescu MA, de La Salmonière P, Dupuy A, Rivet J, Rybojad M, Dubertret L, Bachelez H, Lebbé C, Morel P.
    Arch Dermatol; 2004 Sep; 140(9):1057-61. PubMed ID: 15381544
    [Abstract] [Full Text] [Related]

  • 2. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R, Rossen K, Ralfkier E, Thomsen K, Skovgaard GL, Jønsson V.
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [Abstract] [Full Text] [Related]

  • 3. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
    Woo DK, Jones CR, Vanoli-Storz MN, Kohler S, Reddy S, Advani R, Hoppe RT, Kim YH.
    Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
    [Abstract] [Full Text] [Related]

  • 4. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA, Talpur R, Bassett RL, Duvic M.
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [Abstract] [Full Text] [Related]

  • 5. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, Canninga-van Dijk MR, Geerts ML, Hebeda KM, Kluin PM, Lam KH, Meijer CJ, Willemze R.
    J Clin Oncol; 2007 Apr 20; 25(12):1581-7. PubMed ID: 17353548
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH, Prinz BM, Guitart J.
    Arch Dermatol; 2005 Mar 20; 141(3):305-11. PubMed ID: 15781671
    [Abstract] [Full Text] [Related]

  • 7. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P, Wickless SC, Rosen S, Kuzel TM, Ciurea A, Havey J, Guitart J.
    J Am Acad Dermatol; 2008 Aug 20; 59(2):245-54. PubMed ID: 18486274
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, von der Maase H, Eggermont AM, Keilholz U, American Joint Committee on Cancer Stage IV Melanoma, EORTC 18951.
    J Clin Oncol; 2007 Apr 20; 25(12):1562-9. PubMed ID: 17443000
    [Abstract] [Full Text] [Related]

  • 9. Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma.
    Benner MF, Willemze R.
    Arch Dermatol; 2009 Dec 20; 145(12):1399-404. PubMed ID: 20026848
    [Abstract] [Full Text] [Related]

  • 10. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A, Colomo L, Camós M, Carreras J, Balague O, Martinez A, Lopéz-Guillermo A, Estrach T, Campo E.
    J Clin Oncol; 2008 Jul 10; 26(20):3364-71. PubMed ID: 18541895
    [Abstract] [Full Text] [Related]

  • 11. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R.
    J Am Acad Dermatol; 2003 Jul 10; 49(1):35-49. PubMed ID: 12833006
    [Abstract] [Full Text] [Related]

  • 12. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J, Schmid K, Trautinger F, Wallnöfer W, Muellauer L, Soleiman A, Knobler R, Haitel A, Pehamberger H, Raderer M.
    J Dermatol Sci; 2011 Dec 10; 64(3):185-90. PubMed ID: 21937200
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul 10; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 14. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 15. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ, Willemze R.
    Br J Dermatol; 2007 Dec 01; 157(6):1205-11. PubMed ID: 17941944
    [Abstract] [Full Text] [Related]

  • 16. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC, Meijer CJ, Van der Putte SC, Hollema H, Geerts ML, Bezemer PD, Willemze R.
    J Pathol; 1994 Jan 01; 172(1):53-60. PubMed ID: 7931828
    [Abstract] [Full Text] [Related]

  • 17. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 01; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 18. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
    Hallermann C, Niermann C, Fischer RJ, Schulze HJ.
    Acta Derm Venereol; 2011 Sep 01; 91(5):521-5. PubMed ID: 21547335
    [Abstract] [Full Text] [Related]

  • 19. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T.
    Arch Dermatol; 2007 Sep 01; 143(9):1144-50. PubMed ID: 17875875
    [Abstract] [Full Text] [Related]

  • 20. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T, Isenhath SN, Polissar NL, Sabath DE, Wood B, Hanke D, Haycox CL, Wood GS, Olerud JE.
    Arch Dermatol; 2005 Sep 01; 141(9):1107-13. PubMed ID: 16172307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.